Altamira Therapeutics (CYTO) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 5, 2023 (10:41)
Sector: HealthcareThe share price of Altamira Therapeutics Ltd. (CYTO) now
50/200 Day Moving Average: $0.208 / $0.763
This figure corresponds to the Average Price over the previous 50/200 days. For Altamira Therapeutics stocks, the 50-day moving average is the support level today.
For Altamira Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Altamira Therapeutics Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Altamira Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Altamira Therapeutics share be worth in 2024 - 2028?
When should I take profit in Altamira Therapeutics stock? When should I record a loss on Altamira Therapeutics stock? What are analysts' forecasts for Altamira Therapeutics stock? What is the future of Altamira Therapeutics stock? We forecast Altamira Therapeutics stock performance using neural networks based on historical data on Altamira Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Altamira Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Altamira Therapeutics shares. This happens once a day.
Historical and forecast chart of Altamira Therapeutics stock
The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Altamira Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Altamira Therapeutics Ltd is committed to the development of therapeutic agents to address unmet medical needs. It is active in the treatment of RNA, allergies and viral infections, as well as in diseases of the inner ear. Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.
Altamira Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 07 | 0.33 | 0.32 | 0.35 | 6.94 |
| Dec 08 | 0.33 | 0.32 | 0.34 | 4.58 |
| Dec 09 | 0.32 | 0.31 | 0.33 | 6.86 |
| Dec 10 | 0.33 | 0.32 | 0.34 | 7.29 |
| Dec 11 | 0.34 | 0.33 | 0.35 | 6.38 |
| Dec 12 | 0.35 | 0.34 | 0.36 | 7.30 |
| Dec 13 | 0.34 | 0.33 | 0.36 | 8.44 |
| Dec 14 | 0.33 | 0.33 | 0.34 | 4.67 |
| Dec 15 | 0.35 | 0.34 | 0.36 | 4.23 |
| Dec 16 | 0.33 | 0.33 | 0.34 | 3.77 |
| Dec 17 | 0.33 | 0.32 | 0.34 | 6.58 |
| Dec 18 | 0.33 | 0.32 | 0.33 | 3.47 |
| Dec 19 | 0.33 | 0.31 | 0.34 | 8.07 |
| Dec 20 | 0.33 | 0.32 | 0.34 | 5.90 |
| Dec 21 | 0.35 | 0.34 | 0.36 | 6.78 |
| Dec 22 | 0.35 | 0.34 | 0.36 | 4.45 |
| Dec 23 | 0.37 | 0.36 | 0.38 | 7.06 |
| Dec 24 | 0.38 | 0.36 | 0.40 | 9.35 |
| Dec 25 | 0.38 | 0.37 | 0.39 | 6.64 |
| Dec 26 | 0.36 | 0.35 | 0.37 | 5.72 |
| Dec 27 | 0.36 | 0.35 | 0.36 | 3.23 |
| Dec 28 | 0.34 | 0.33 | 0.35 | 6.72 |
| Dec 29 | 0.35 | 0.34 | 0.36 | 5.86 |
| Dec 30 | 0.34 | 0.33 | 0.35 | 7.01 |
| Dec 31 | 0.34 | 0.33 | 0.35 | 3.48 |
| Jan 01 | 0.35 | 0.34 | 0.36 | 5.17 |
| Jan 02 | 0.34 | 0.33 | 0.35 | 7.98 |
| Jan 03 | 0.35 | 0.33 | 0.35 | 6.63 |
| Jan 04 | 0.33 | 0.32 | 0.35 | 8.71 |
| Jan 05 | 0.33 | 0.32 | 0.34 | 4.40 |
Altamira Therapeutics Daily Price Targets
Altamira Therapeutics Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $0.33.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 6.492%.
Pessimistic target level: 0.32
Optimistic target level: 0.35
Altamira Therapeutics Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $0.33.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 4.376%.
Pessimistic target level: 0.32
Optimistic target level: 0.34
Altamira Therapeutics Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $0.32.
Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 6.418%.
Pessimistic target level: 0.31
Optimistic target level: 0.33
Altamira Therapeutics Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $0.33.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 6.792%.
Pessimistic target level: 0.32
Optimistic target level: 0.34
Altamira Therapeutics Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $0.34.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 5.994%.
Pessimistic target level: 0.33
Optimistic target level: 0.35
Altamira Therapeutics Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $0.35.
Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 6.800%.
Pessimistic target level: 0.34
Optimistic target level: 0.36
CYTO (CYTO) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan. | 0.36 | 0.31 | 0.37 | 16.73 |
| Feb. | 0.40 | 0.34 | 0.42 | 18.70 |
| Mar. | 0.39 | 0.34 | 0.44 | 22.11 |
| Apr. | 0.41 | 0.38 | 0.46 | 19.20 |
| May. | 0.40 | 0.35 | 0.44 | 19.27 |
| Jun. | 0.41 | 0.37 | 0.45 | 17.55 |
| Jul. | 0.42 | 0.40 | 0.47 | 16.55 |
| Aug. | 0.38 | 0.36 | 0.42 | 13.66 |
| Sep. | 0.37 | 0.34 | 0.42 | 19.86 |
| Oct. | 0.33 | 0.29 | 0.36 | 17.44 |
| Nov. | 0.36 | 0.34 | 0.38 | 10.71 |
| Dec. | 0.35 | 0.32 | 0.41 | 22.78 |
Altamira Therapeutics forecast for this year
Altamira Therapeutics Stock Prediction for Jan 2024
An uptrend is forecast for this month with an optimal target price of $0.358556. Pessimistic: $0.31. Optimistic: $0.37
Altamira Therapeutics Stock Prediction for Feb 2024
An uptrend is forecast for this month with an optimal target price of $0.401583. Pessimistic: $0.34. Optimistic: $0.42
Altamira Therapeutics Stock Prediction for Mar 2024
An downtrend is forecast for this month with an optimal target price of $0.387126. Pessimistic: $0.34. Optimistic: $0.44
Altamira Therapeutics Stock Prediction for Apr 2024
An uptrend is forecast for this month with an optimal target price of $0.405708. Pessimistic: $0.38. Optimistic: $0.46
Altamira Therapeutics Stock Prediction for May 2024
An downtrend is forecast for this month with an optimal target price of $0.401651. Pessimistic: $0.35. Optimistic: $0.44
Altamira Therapeutics Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $0.407274. Pessimistic: $0.37. Optimistic: $0.45
Altamira Therapeutics Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $0.417048. Pessimistic: $0.40. Optimistic: $0.47
Altamira Therapeutics Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $0.381182. Pessimistic: $0.36. Optimistic: $0.42
Altamira Therapeutics Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $0.371271. Pessimistic: $0.34. Optimistic: $0.42
Altamira Therapeutics Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $0.331174. Pessimistic: $0.29. Optimistic: $0.36
Altamira Therapeutics Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $0.357668. Pessimistic: $0.34. Optimistic: $0.38
Altamira Therapeutics Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $0.354807. Pessimistic: $0.32. Optimistic: $0.41
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.39 | 0.34 | 0.42 | 18.42 |
| Feb | 0.46 | 0.44 | 0.53 | 17.31 |
| Mar | 0.48 | 0.43 | 0.53 | 18.87 |
| Apr | 0.57 | 0.51 | 0.62 | 17.79 |
| May | 0.67 | 0.60 | 0.75 | 18.81 |
| Jun | 0.73 | 0.61 | 0.82 | 25.18 |
| Jul | 0.76 | 0.72 | 0.80 | 9.68 |
| Aug | 0.81 | 0.71 | 0.91 | 21.04 |
| Sep | 0.88 | 0.84 | 1.00 | 15.82 |
| Oct | 0.94 | 0.86 | 1.06 | 18.29 |
| Nov | 0.89 | 0.77 | 0.98 | 20.99 |
| Dec | 0.92 | 0.82 | 1.03 | 20.71 |
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.91 | 0.80 | 0.98 | 18.52 |
| Feb | 1.02 | 0.91 | 1.09 | 16.57 |
| Mar | 1.18 | 1.08 | 1.27 | 14.37 |
| Apr | 1.09 | 0.99 | 1.22 | 19.22 |
| May | 1.02 | 0.98 | 1.09 | 10.47 |
| Jun | 0.91 | 0.77 | 1.00 | 23.22 |
| Jul | 0.90 | 0.83 | 0.96 | 13.46 |
| Aug | 0.96 | 0.92 | 1.00 | 7.87 |
| Sep | 1.05 | 0.94 | 1.14 | 17.80 |
| Oct | 1.25 | 1.20 | 1.44 | 17.01 |
| Nov | 1.36 | 1.17 | 1.57 | 25.22 |
| Dec | 1.44 | 1.32 | 1.60 | 17.69 |
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.65 | 1.55 | 1.91 | 18.72 |
| Feb | 1.86 | 1.64 | 2.02 | 18.45 |
| Mar | 2.18 | 1.85 | 2.44 | 24.24 |
| Apr | 2.26 | 2.13 | 2.35 | 9.42 |
| May | 1.83 | 1.66 | 2.00 | 17.18 |
| Jun | 1.87 | 1.63 | 2.17 | 24.83 |
| Jul | 1.85 | 1.73 | 2.07 | 16.31 |
| Aug | 1.91 | 1.75 | 2.19 | 20.10 |
| Sep | 1.85 | 1.70 | 2.04 | 16.39 |
| Oct | 1.88 | 1.65 | 2.17 | 23.92 |
| Nov | 2.03 | 1.87 | 2.25 | 16.82 |
| Dec | 2.32 | 2.16 | 2.54 | 14.81 |
Altamira Therapeutics (CYTO) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.41 | 2.29 | 2.77 | 17.25 |
| Feb | 2.74 | 2.52 | 2.90 | 13.37 |
| Mar | 2.55 | 2.34 | 2.68 | 12.76 |
| Apr | 2.69 | 2.56 | 2.96 | 13.45 |
| May | 2.85 | 2.60 | 3.14 | 17.09 |
| Jun | 2.97 | 2.71 | 3.28 | 17.39 |
| Jul | 2.96 | 2.51 | 3.30 | 23.97 |
| Aug | 2.69 | 2.30 | 2.92 | 21.03 |
| Sep | 2.96 | 2.60 | 3.36 | 22.44 |
| Oct | 2.67 | 2.31 | 2.99 | 22.99 |
| Nov | 2.81 | 2.65 | 3.15 | 15.89 |
| Dec | 2.81 | 2.51 | 3.10 | 19.02 |
Altamira Therapeutics information and performance
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM 11, BM
Market capitalization of the Altamira Therapeutics Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CYTO shares in the company outstanding by the market price of one share.
EBITDA of Altamira Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Altamira Therapeutics (CYTO) stock dividend
Altamira Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 05/01/2019. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
